STOCK TITAN

Pfizer (NYSE: PFE) files Form 13F listing $236,464,562 across 21 entries

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
13F-HR

Rhea-AI Filing Summary

Pfizer Inc filed a Form 13F reporting its institutional holdings. The report lists 21 securities entries with a total reported market value of $236,464,562 as shown on the Form 13F summary page. The filing was signed by Madelyn D. Purcell, Assistant General Counsel on 02-10-2026.

Positive

  • None.

Negative

  • None.

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F COVER PAGE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

Report for the Calendar Year or Quarter Ended: 12-31-2025
Check here if Amendment Amendment Number:
This Amendment (Check only one.): is a restatement.
adds new holdings entries.
Institutional Investment Manager Filing this Report:
Name: Pfizer Inc
Address: 66 Hudson Boulevard East
New York, NY 10001-2192
Form 13F File Number: 028-25239
CRD Number (if applicable):
SEC File Number (if applicable):

The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form.

Person Signing this Report on Behalf of Reporting Manager:
Name: Madelyn D. Purcell
Title: Assistant General Counsel
Phone: 212-733-4293
Signature, Place, and Date of Signing:
/s/ Madelyn D. Purcell New York, NY 02-10-2026
[Signature] [City, State] [Date]
Report Type (Check only one.):
X 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.)
13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).)
13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).)
Form 13F Summary Page
Report Summary:
Number of Other Included Managers: 0
Form 13F Information Table Entry Total: 21
Form 13F Information Table Value Total: 236,464,562
(round to nearest dollar)
List of Other Included Managers:
Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report.
[If there are no entries in this list, state "NONE" and omit the column headings and list entries.]
NONE

FAQ

What does Pfizer's (PFE) Form 13F disclose?

The Form 13F discloses institutional holdings for Pfizer as the reporting manager. It lists 21 reported securities entries and a total market value of $236,464,562, signed on 02-10-2026 by Madelyn D. Purcell.

Does the PFE 13F show specific share counts or positions?

This excerpt provides the number of entries and aggregate value only. It does not include specific share counts, per‑holding quantities, or individual security names in the provided content.

Who certified Pfizer's Form 13F filing for PFE?

The filing was signed and certified by Madelyn D. Purcell, Assistant General Counsel, on 02-10-2026, representing the reporting manager and attesting to the report's accuracy as presented on the cover page.

How many holdings and what total value did Pfizer report in the 13F?

Pfizer reported 21 Form 13F information table entries with a combined market value of $236,464,562 as shown on the Form 13F summary page in this filing excerpt.
Pfizer

NYSE:PFE

View PFE Stock Overview

PFE Rankings

PFE Latest News

PFE Latest SEC Filings

PFE Stock Data

161.09B
5.68B
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States
NEW YORK